With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Routine tests in the third trimester may catch missed cases and flag the need for treatment that reduces a baby‘s risk of getting HIV to near zero.

The stock has underperformed the industry so far this year, as shown in the chart below. Image Source: Zacks Investment Research Merck is building a competitive HIV franchise, targeting both ...

About 20 million Americans have macular degeneration – a condition that damages vision and can cause blindness. Now, a doctor ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Twice-a-year shot to prevent HIV could stop transmission — if people can get it Tests found that new drug nearly eliminated new infections. By The Associated Press Wire Service Jun. 18, 2025 ...

The National Agency for the Control of AIDS has announced plans to convene the seventh National Council on AIDS, which will focus on Nigeria’s HIV response in the context of evolving global aid ...

Californians, starting next year, will be able to access HIV prevention medications without a prescription. Gov. Gavin Newsom signed a bill into law on Monday, making California the first state in ...

About 2.5 million take PrEP, WHO said. More than 39,000 U.S. residents were diagnosed with HIV in 2023, according to the Centers for Disease Control and Prevention.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...